Ceritinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Ceritinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. Your doctor will test for the presence of this gene. Ceritinib is an antineoplastic (cancer) agent.Ceritinib Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Ceritinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)-N-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of Ceritinib Nitroso Impurity 2 . We supply Ceritinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142708 |
| CAS No | NA |
| Mol.F. | C14H19N3O2 |
| Mol.Wt. | 261.33 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142709 |
| CAS No | NA |
| Mol.F. | C14H13N3O2 |
| Mol.Wt. | 255.28 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142710 |
| CAS No | NA |
| Mol.F. | C15H20ClN3O2 |
| Mol.Wt. | 309.79 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142711 |
| CAS No | NA |
| Mol.F. | C15H21N3O3 |
| Mol.Wt. | g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142712 |
| CAS No | NA |
| Mol.F. | C18H22N4O2 |
| Mol.Wt. | 326.39 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142713 |
| CAS No | NA |
| Mol.F. | C18H22N4O2 |
| Mol.Wt. | 326.40 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142714 |
| CAS No | NA |
| Mol.F. | C27H21Cl2N5O |
| Mol.Wt. | 502.4 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142715 |
| CAS No | NA |
| Mol.F. | C27H22ClN5O |
| Mol.Wt. | 467.96 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142716 |
| CAS No | NA |
| Mol.F. | C24H14Cl2N4O2 |
| Mol.Wt. | 461.30 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142717 |
| CAS No | NA |
| Mol.F. | C12H10ClN3O |
| Mol.Wt. | 247.68 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142718 |
| CAS No | NA |
| Mol.F. | C24H15Cl2N5O |
| Mol.Wt. | 460.32 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142719 |
| CAS No | NA |
| Mol.F. | C27H22ClN5O |
| Mol.Wt. | 467.96 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142720 |
| CAS No | NA |
| Mol.F. | C12H8ClN3O3 |
| Mol.Wt. | 277.66 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142721 |
| CAS No | NA |
| Mol.F. | C24H19Cl2N5O |
| Mol.Wt. | 464.35 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142722 |
| CAS No | NA |
| Mol.F. | C24H19Cl2N5O |
| Mol.Wt. | 464.35 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142723 |
| CAS No | NA |
| Mol.F. | C24H16ClN5O |
| Mol.Wt. | 425.88 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |